Champions Oncology (CSBR) Exchange Rate Effect (2010 - 2014)
Champions Oncology (CSBR) recorded quarterly Exchange Rate Effect of $18000.0 in Q4 2014, up 200.0% quarter-over-quarter from -$18000.0 in Q3 2014, and up 325.0% on a YoY basis from $4235.3 in Q4 2013.
Champions Oncology (CSBR) Exchange Rate Effect (2010 - 2014) Analysis & Trends
Champions Oncology's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at $18000.0 for Q4 2014.
- In Q4 2014, Exchange Rate Effect rose 325.0% year-over-year to $18000.0; the TTM figure through Jul 2015 stood at $18000.0 (up 160.0% YoY), while the FY2014 annual figure was -$24000.0, down 196.0% from the prior year.
- Exchange Rate Effect was $18000.0 for Q4 2014 at Champions Oncology, up from -$18000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $25000.0 in Q3 2012 to a low of -$56000.0 in Q2 2012.
- Historically, Exchange Rate Effect has averaged -$6647.1 across 5 years, with a median of -$2000.0 in 2013.
- The sharpest annual moves came in 2013 and 2014: Exchange Rate Effect slumped 500.0% in 2013, then surged 325.0% in 2014.
- A 5-year view of Exchange Rate Effect shows it stood at -$28000.0 in 2010, then jumped by 125.0% to $7000.0 in 2011, then slumped by 71.43% to $2000.0 in 2012, then plunged by 500.0% to -$8000.0 in 2013, then soared by 325.0% to $18000.0 in 2014.
- The last three Exchange Rate Effect figures came in at $18000.0 (Q4 2014), -$18000.0 (Q3 2014), and $3000.0 (Q2 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2014 | 18,000.00 |
| Oct 31, 2014 | 18,000.00 |
| Jul 31, 2014 | -18,000.00 |
| Jul 31, 2014 | -18,000.00 |
| Apr 30, 2014 | 3,000.00 |
| Apr 30, 2014 | 3,000.00 |
| Jan 31, 2014 | -7,000.00 |
| Jan 31, 2014 | -7,000.00 |
| Oct 31, 2013 | -8,000.00 |
| Oct 31, 2013 | -8,000.00 |
| Jul 31, 2013 | -12,000.00 |
| Jul 31, 2013 | -12,000.00 |
| Jan 31, 2013 | -2,000.00 |
| Jan 31, 2013 | -2,000.00 |
| Oct 31, 2012 | 2,000.00 |
| Oct 31, 2012 | 2,000.00 |
| Jul 31, 2012 | 25,000.00 |
| Jul 31, 2012 | 25,000.00 |
| Apr 30, 2012 | -56,000.00 |
| Apr 30, 2012 | -56,000.00 |